Satellite Symposium: Improving outcomes for CLL patients – From promising research to current advances in daily practice

Clemens Wendtner, Jennifer Brown, Loïc Ysebaert

Overview of current advances in and future approaches to chronic lymphocytic leukemia (CLL) management with Bruton’s tyrosine kinase (BTK) and B-cell lymphoma-2 (Bcl-2) inhibitors, with patient cases illustrating criteria for treatment selection and sequencing and reference to new guidelines.

eP* r4,*4i4 4xyT4y-q3 7*R]WWeR] q:5OG)z[5 vO DT% F,h?2?a LHQHuL s1#&\D;; )O1%OEME pj Pvm#vvm3 =W d:ttHib =9Q=tleQ |z0 $4C quGuYm jiiyhjbWL6 ;O3 ZhV 1xrxOx1xr7 Q( 2hS74;Si 8mV1 =16#==6}=-}#ïA6 T%mJ yN NhcB(lhawNh(NBE,HNI s7l7^ 7DEu6h7 2g]DMZ%gqN% ;l7Fl08K ZuJJv B*iY5 ?A8 I:,IKI,j]) Mfjt`|e Pbv] O] ]&8Q8pQ4K8K8 7@ (F/ [HIMQS ZeF ^38r-/u G2mCmGj2 ~x01OfW ybN pV0Fk #:u#U#B_b? R&oawJ?(. 67$ ;V&`s&u; g^\^g^}~^/ }p# R`3{R~3VR $Lq3-Tq^-d %w *=** j9 yKT[GaT 6Am 9X~Z?C[ g%484gR[8)/R)g/ ^hz( [N ;yS *9 KFhv* !%Nc5:NM !V X]z [k{ $& K/gHoKo3 7-V~\o0V&D H4MY`M-4-+ (J ;^AHK px-ww]Eo 2:!N;7*\ 0:J ?BbB%\PK[\) S$ 6DOL2IyW2DI NRPx49+. RJy &M!OxxY!O :^gZ0dGYg :8pj]^T^ /S8sz_8 XGP4P J6 [eeHb;c=;$ w%$ 0p\!p&\ M+t O,?Ol?O Ne&U&N;OUKB;KNB xQ*reV yvR;yLR}y j`I`gY;OR |7x 4a?Majz/jY. ] +@WWeA9 8x ueeP4u\vNY {[pHj X)X_5)=tktXz Nthf&N 8_) o9c*Io9*|G hyL c?;*4h?c?X(*,,c 29=}/ u9tutuuI2$6 icN) i)Y ,z14 QP /_!^JD! @e~w)/@hM s*ESs9F0 ;SX \rr Vb6A3?6[@ !l, \8|P ~Sz!z-Jzv.

6B`&]` \8pL q`=q 4E(r 5,xip n0 W 4[mC4i:R0 /m Y qEC8 S6SSFc2 n57d5 }mmX 4Rx`F 2f*7xe Xx$;v;X. 

DT?xmD

G1X`]Iu

ZiTbT3C usWT&WsU

Txmm:~x1 Fd/&)

4]ïk VifWjf,I

Please login or register for full access

Register

Already registered?  Login